Ribotest Biotech Launches Hong Kong IPO Offering 27.4874 Million H Shares
Start here
Ribotest Biotech (06938.HK) launched its Hong Kong Stock Exchange offering on December 31, 2025, planning a global sale of 27.4874 million H shares at HK$57.97 per share. Listing is expected on January 9, 2026, with CICC and Citi acting as joint sponsors.
Excerpted from VBData
Coverage timeline
Follow the coverage to see the different angles.
- VBDataPickRibotest Biotech Launches Hong Kong IPO Offering 27.4874 Million H Shares
Ribotest Biotech (06938.HK) launched its Hong Kong Stock Exchange offering on December 31, 2025, planning a global sale of 27.4874 million H shares at HK$57.97 per share. Listing is expected on January 9, 2026, with CICC and Citi acting as joint sponsors.
Coverage and heat for this story
Reports so far 1·Heat now 9·Peak heat 10 (Oct 19 11:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.